Cell freezing medium is a complete cell freezing media for mammalian cell cultures.
Most classic formulations of cell freezing media containing dimethyl sulfoxide (DMSO) as the active freezing agent. However, since it is known that DMSO is a mutagen and carcinogen, DMSO-free formulations are becoming popular for stem cell applications. This is an especially critical consideration for cells being used in translational research or clinical applications. Moreover, media formulations that are manufactured under GMP compliance and have drug-master files registered with government regulatory agencies provide added value for regenerative medicine use.
Market competition is intense. BioLife Solutions, Thermo Fisher Scientific, Merck, GE Healthcare, Zenoaq, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. The Top 5 manufacturers occupied 87.85% of global market share in 2019.

Market Analysis and Insights: Global and China Cell Freezing Media for Cell Therapy Market
This report focuses on global and China Cell Freezing Media for Cell Therapy market.
In 2020, the global Cell Freezing Media for Cell Therapy market size was US$ 59 million and it is expected to reach US$ 141.2 million by the end of 2027, with a CAGR of 13.2% during 2021-2027. In China the Cell Freezing Media for Cell Therapy market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Cell Freezing Media for Cell Therapy Scope and Market Size
Cell Freezing Media for Cell Therapy market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cell Freezing Media for Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Cell Freezing Media for Cell Therapy market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
With FBS
Without FBS

Segment by Application
Human Embryonic Stem Cells
CAR-T Cell Therapy
Neural Stem Cell Therapy
Mesenchymal Stem Cell Therapy
Hematopoietic Stem Cell Transplantation
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
BioLife Solutions
Thermo Fisher Scientific
Merck
GE Healthcare
Zenoaq